Whole-genome analysis informs breast cancer response to aromatase inhibition.
Times cited: 540
A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer.
JAMA - Journal of the American Medical Association.
Times cited: 243
Phosphatidyl-inositol-3-kinase alpha catalytic subunit mutation and response to neoadjuvant endocrine therapy for estrogen receptor positive breast cancer.
Breast Cancer Research and Treatment.
Times cited: 76